Propofol

Journal of Pain and Symptom Management

Volumn 40, Issue 3, 2010, Pages 466-470

  Lundström, Staffan ^a   Twycross, Robert ^b   Mihalyo, Mary ^c   Wilcock, Andrew ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c DUQUESNE UNIVERSITY   (United States)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BENZODIAZEPINE; CHLORPROMAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LIDOCAINE; PHENOBARBITAL; PROPOFOL;

ANESTHESIA INDUCTION; APNEA; BRADYCARDIA; CONSCIOUS SEDATION; DELIRIUM; DISTRESS SYNDROME; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG INFORMATION; GENERAL ANESTHESIA; HEADACHE; HEALTH PRACTITIONER; HOSPICE CARE; HUMAN; HYPOTENSION; INJECTION SITE PAIN; NAUSEA AND VOMITING; PALLIATIVE THERAPY; PHLEBITIS; POSTOPERATIVE VOMITING; REVIEW; SEDATION; THROMBOSIS; TREATMENT INDICATION;

EID: 77956401055     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.07.001     Document Type: Short Survey

References (29)

1. S. Lundström, U. Zachrisson, and C.J. Fürst When nothing helps: propofol as sedative and antiemetic in palliative cancer care J Pain Symptom Manage 30 2005 570 577
2. Anonymous. Propofol (Diprivan) infusion: sedation in children aged 16 years or younger contraindicated Curr Probl Pharmacovigilance 27 2001 10
3. E.A. Harris Sedation and anesthesia options for pediatric patients in the radiation oncology suite Int J Pediatr 2010 Epub 2010 May 13, article ID 870921
4. K.N. Hofer, M.W. McCarthy, M.L. Buck, and A.E. Hendrick Possible anaphylaxis after propofol in a child with food allergy Ann Pharmacother 37 2003 398 401
5. J. Mirenda, and G. Broyles Propofol as used for sedation in the ICU Chest 108 1995 539 548
6. K. McWilliams, P.W. Keeley, and E.T. Waterhouse Propofol for terminal sedation in palliative care: a systematic review J Palliat Medicine 13 2010 73 76
7. M.C. Hooke, E. Grund, and H. Quammen Propofol use in pediatric patients with severe cancer pain at the end of life J Pediatr Oncol Nurs 24 2007 29 34
8. M. Tramr, A. Moore, and H. McQuay Meta-analytic comparison of prophylactic antiemetic efficacy for postoperative nausea and vomiting: propofol anaesthesia vs omitting nitrous oxide vs total i.v. anaesthesia with propofol Br J Anaesth 78 1997 256 259
9. J.R. Sneyd, A. Carr, W.D. Byrom, and A.J. Bilski A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents Eur J Anaesthesiol 15 1998 433 445
10. P. DeBalli The use of propofol as an antiemetic Int Anesthesiol Clin 41 2003 67 77
11. T.J. Gan, P.S. Glass, and S.T. Howell Determination of plasma concentrations of propofol associated with 50% reduction in postoperative nausea Anesthesiology 87 1997 779 784
12. T.J. Gan, H. El-Molem, J. Ray, and P.S. Glass Patient-controlled antiemesis: a randomized, double-blind comparison of two doses of propofol versus placebo Anesthesiology 90 1999 1564 1570
13. Y. Fujii, H. Tanaka, and N. Kobayashi Small doses of propofol, droperidol, and metoclopramide for the prevention of postoperative nausea and vomiting after thyroidectomy Otolaryngol Head Neck Surg 124 2001 266 269
14. C.S. Scher, D. Amar, R.H. McDowall, and S.M. Barst Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients Can J Anaesth 39 1992 170 172
15. A. Borgeat, O. Wilder-Smith, M. Forni, and P.M. Suter Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer Can J Anaesth 41 1994 1117 1119
16. D.F. Cechetto, T. Diab, C.J. Gibson, and A.W. Gelb The effects of propofol in the area postrema of rats Anesth Analg 92 2001 934 942
17. J.J. García Peñas, A. Molins, and J. Salas Puig Status epilepticus: evidence and controversy Neurologist 13 6 Suppl. 1 2007 S62 S73
18. A.O. Rossetti Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia 48 Suppl 8 2007 52 55
19. J.R. Sneyd Propofol and epilepsy Br J Anaesth 82 1999 168 169
20. S. Meyer, U. Grundmann, B. Kegel, L. Gortner, and G. Shamdeen Propofol: pro- or anticonvulsant drug? Anesth Analg 108 6 2009 1993 1994 author reply 1994
21. C. Jungheinrich, R. Scharpf, M. Wargenau, C. Dilger, and F. Bepperling Pharmacokinetics of the generic formulation propofol 1% fresenius in comparison with the original formulation (Disoprivan 1%) Clin Drug Investig 22 7 2002 417 427
22. J. Fechner, H. Ihmsen, and D. Hatterscheid Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion Anesthesiology 101 2004 626 639
23. AstraZeneca. Data on file. 2006.
24. F. Charatan Concerns mount over misuse of anaesthetic propofol among US health professionals Br Med J 2009 339 b3673
25. C. Wilson, P. Canning, and E.M. Caravati The abuse potential of propofol Clin Toxicol 48 2010 165 170
26. AstraZeneca. Personal communication. 2010.
27. S. Mercadante, F. De Conno, and C. Ripamonti Propofol in terminal care J Pain Symptom Manage 10 1995 639 642
28. J. Moyle The use of propofol in palliative medicine J Pain Symptom Manage 10 1995 643 646
29. C. Cheng, C. Roemer-Becuwe, and J. Pereira When midazolam fails J Pain Symptom Manage 23 2002 256 265